July 7, 2017 — Blood clots in veins and arteries can lead to heart attack, stroke and pulmonary embolism, which are major causes of mortality. In the featured article of The Journal of Nuclear Medicine’s (JNM) July 2017 issue, German researchers show that targeting GPIIb/IIIa receptors, the key receptor involved in platelet clumping, with a fluorine-18 (18F) labeled ligand is a promising approach for diagnostic imaging.
PET, SPECT Capture Cell Death in 3D
Attrius Cardiac PET Scanner Used to Image Amyloid Plaques in Brain at N.J. Facility
Diagnostic and Interventional Cardiology
AI Tool Predicts Reduced Blood Flow to the Heart
Nuclear Scanner Failures Detected With Real-Time Monitoring
Lantheus to Study Safety of Novel PET Agent for Heart Failure
Study on Novel Cardiac PET Tracer Launches
Home Imaging Technology News
Radiopharmaceuticals and Tracers
PET Fludeoxyglucose F18 Injection Gains FDA Clearance
Manhattan Isotope Technology Receives License Amendment Approval for Strontium-82
AI Tool Predicts Reduced Blood Flow to the Heart
Radiopharmaceuticals and Tracers
Simple, low-cost fix improves optical scanning technique (OCT) – Science Mission
Radiopharmaceuticals and Tracers
